BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7874523)

  • 1. Stimulus intensity and the comparative efficacy of mu- and kappa-opioid agonists on nociceptive spinal reflexes in the rat.
    Thorn SA; Herrero JF; Headley PM
    Brain Res; 1994 Nov; 663(2):352-6. PubMed ID: 7874523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of sham and full spinalization on the systemic potency of mu- and kappa-opioids on spinal nociceptive reflexes in rats.
    Herrero JF; Headley PM
    Br J Pharmacol; 1991 Sep; 104(1):166-70. PubMed ID: 1664760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal antinociceptive actions of mu- and kappa-opioids: the importance of stimulus intensity in determining 'selectivity' between reflexes to different modalities of noxious stimulus.
    Parsons CG; Headley PM
    Br J Pharmacol; 1989 Oct; 98(2):523-32. PubMed ID: 2555011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinal antinociceptive actions and naloxone reversibility of intravenous mu- and kappa-opioids in spinalized rats: potency mismatch with values reported for spinal administration.
    Parsons CG; West DC; Headley PM
    Br J Pharmacol; 1989 Oct; 98(2):533-43. PubMed ID: 2555012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intravenous mu and kappa opioid receptor agonists on sensory responses of convergent neurones in the dorsal horn of spinalized rats.
    Dong XW; Parsons CG; Headley PM
    Br J Pharmacol; 1991 May; 103(1):1230-6. PubMed ID: 1652344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar actions of kappa and mu agonists on spinal nociceptive reflexes in rats and their reversibility by naloxone.
    Parsons CG; West DC; Headley PM
    NIDA Res Monogr; 1986; 75():461-4. PubMed ID: 2828992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the selectivity of intravenous mu- and kappa-opioids between nociceptive and non-nociceptive reflexes in the spinalized rat.
    Parsons CG; Headley PM
    Br J Pharmacol; 1989 Oct; 98(2):544-51. PubMed ID: 2555013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-tolerance to acute administration of mu and kappa opioid agonists at the spinal cord level in the rat.
    Laurido C; Hernandez A; Perez H
    Int J Neurosci; 1996 Nov; 87(3-4):191-9. PubMed ID: 9003979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional evidence for multiple receptor activation by kappa-ligands in the inhibition of spinal nociceptive reflexes in the rat.
    Herrero JF; Headley PM
    Br J Pharmacol; 1993 Sep; 110(1):303-9. PubMed ID: 8220893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of selective and non-selective kappa-opioid receptor agonists on cutaneous C-fibre-evoked responses of rat dorsal horn neurones.
    Knox RJ; Dickenson AH
    Brain Res; 1987 Jul; 415(1):21-9. PubMed ID: 2887243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
    Millan MJ; Członkowski A; Lipkowski A; Herz A
    J Pharmacol Exp Ther; 1989 Oct; 251(1):342-50. PubMed ID: 2571723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
    Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
    J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of mu-, delta- and kappa-opiate receptor agonists on the bioelectrical activity of the viscerosomatic convergent neurons in the posterior horn of the spinal cord].
    Kasparov SA
    Eksp Klin Farmakol; 1993; 56(1):13-6. PubMed ID: 8391888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct antinociceptive actions mediated by different opioid receptors in the region of lamina I and laminae III-V of the dorsal horn of the rat.
    Hope PJ; Fleetwood-Walker SM; Mitchell R
    Br J Pharmacol; 1990 Oct; 101(2):477-83. PubMed ID: 2175238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
    Picker MJ; Dykstra LA
    J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal analgesic actions of kappa receptor agonists, U-50488H and spiradoline (U-62066).
    Piercey MF; Einspahr FJ
    J Pharmacol Exp Ther; 1989 Oct; 251(1):267-71. PubMed ID: 2552077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between the discriminative stimulus effects of mu and kappa opioid agonists in the squirrel monkey.
    Negus SS; Picker MJ; Dykstra LA
    J Pharmacol Exp Ther; 1991 Jan; 256(1):149-58. PubMed ID: 1846412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium channel modulators modify K opioid-induced inhibition of C-fiber-evoked spinal reflexes in rat.
    Hernández A; Contreras E; Paeile C; Pérez H; Pelissier T; Quijada L; Soto-Moyano R
    Int J Neurosci; 1993 Oct; 72(3-4):167-74. PubMed ID: 7511132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The NSAID dexketoprofen trometamol is as potent as mu-opioids in the depression of wind-up and spinal cord nociceptive reflexes in normal rats.
    Mazario J; Roza C; Herrero JF
    Brain Res; 1999 Jan; 816(2):512-7. PubMed ID: 9878876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
    Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y
    Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.